|
|
Fadime Akman, Rachel A. Cooper, Mehmet Şen,
Yildiray Tanriver, Süleyman Kentli
Validation of the Medical Research Council and A Newly Developed Prognostic
Index in Patients with Malignant Glioma:
How useful are Prognostic Indices in
Routine Clinical Practice?
Journal of Neuro-Oncology, 59 (1): 39-47, August 2002
Abstract |
Reprint
|
|
|
Antonelli
M, Buttarelli FR, Arcella A, Nobusawa S, Donofrio V, Oghaki H, Giangaspero F
Prognostic significance of histological grading, p53 status, YKL-40
expression, and IDH1 mutations in pediatric high-grade gliomas
J Neurooncol. 2010 Feb 21;. [Epub ahead of print]
Abstract |
Full Text |
Reprint
|
|
Arifin MT, Hama S, Kajiwara Y, Sugiyama K, Saito
T, Matsuura S, Yamasaki F, Arita K, Kurisu K.
Cytoplasmic, but not nuclear, p16 expression
may signal poor prognosis in high-grade astrocytomas.
J Neurooncol. 2006 May;77(3):273-7. Epub
2006 Apr 14.
Abstract
|
|
|
Barnholtz-Sloan JS, Williams VL, Maldonado JL, Shahani D, Stockwell HG, Chamberlain M, Sloan
AE
Patterns of care and outcomes among elderly individuals with primary
malignant astrocytoma
J Neurosurg. 2008 Apr;108(4):642-648
Abstract |
Full Text |
Reprint
|
|
Paul D. Brown, Ashley
W. Jensen, Sara J. Felten, Karla V. Ballman, Paul
L. Schaefer, Kurt A. Jaeckle, Jane H. Cerhan, Jan
C. Buckner
Detrimental Effects of Tumor Progression on
Cognitive Function of Patients With High-Grade Glioma
Journal of Clinical Oncology, Vol 24, No 34 (December 1), 2006: pp.
5427-5433. DOI: 10.1200/JCO.2006.08.5605
|
|
|
Burnet NG, Lynch AG, Jefferies SJ, Price SJ,
Jones PH, Antoun NM, Xuereb JH, Pohl U.
High grade glioma: Imaging combined with pathological grade defines
management and predicts prognosis
Radiother
Oncol. 2007 Nov 26; [Epub ahead of print]
Abstract
|
|
Dehais C, Laigle-Donadey F, Marie Y, Kujas M,
Lejeune J, Benouaich-Amiel A, Pedretti M, Polivka M, Xuan KH, Thillet J,
Delattre JY, Sanson M.
Prognostic stratification of patients with anaplastic gliomas according to
genetic profile.
Cancer. 2006 Sep 19; [Epub ahead of print]
Abstract
|
|
|
Antje Ernst-Stecken, Oliver Ganslandt,
Ulrike Lambrecht, Rolf Sauer and Gerhard Grabenbauer
Survival and quality of life after hypofractionated stereotactic
radiotherapy for recurrent malignant glioma
J Neurooncol. 2006 Sep 20; [Epub ahead of
print]
Abstract
|
|
|
Adília Hormigo, Bin Gu,
Sasan Karimi, Elyn Riedel, Katherine S.
Panageas, Mark A. Edgar, Meena K. Tanwar, Jasti
S. Rao, Martin Fleisher, Lisa M. DeAngelis
and Eric C. Holland
YKL-40 and Matrix Metalloproteinase-9 as Potential Serum Biomarkers for
Patients with High-Grade Gliomas
Clin
Cancer Res. 2006 Oct 1;12(19):5698-704.
|
|
|
Laks
DR, Masterman-Smith M, Visnyei K, Angenieux B, Orozco NM, Foran I, Yong WH,
Vinters HV, Liau LM, Lazareff JA, Mischel PS, Cloughesy TF, Horvath S,
Kornblum HI
Neurosphere formation is an independent predictor of clinical outcome in
malignant glioma
Stem Cells. 2009 Apr;27(4):980-7
Abstract
|
|
|
Lin
Y, Jiang T, Zhou K, Xu L, Chen B, Li G, Qiu X, Jiang T, Zhang W, Song SW
Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade
gliomas
Neuro Oncol. 2009 Jan 22. [Epub ahead of print]
Abstract
|
|
|
Lorenzoni
J, Torrico A, Villanueva P, Gederlini A, Torrealba G
Surgery for high-grade gliomas in a developing country: survival estimation
using a simple stratification system
Surg Neurol. 2008 Apr 25; [Epub ahead of print]
Abstract
|
|
|
McGirt MJ, Chaichana KL, Gathinji M, Attenello
FJ, Than K, Olivi A, Weingart JD, Brem H, Quiñones-Hinojosa A
Independent association of extent of resection with survival in patients
with malignant brain astrocytoma
J Neurosurg. 2008 Oct 10; [Epub ahead of print]
Abstract
|
|
|
Martinez
R, Janka M, Soldner F, Behr R.
Gross-total Resection of Malignant Gliomas in Elderly Patients: Implications in Survival.
Zentralbl
Neurochir. 2007 Oct 26; [Epub ahead of print]
Abstract
|
|
|
Narayana
A, Perretta D, Kunnakkat S, Gruber D, Golfinos J, Parker E, Medabalmi P,
Zagzag D, Pat Eagan RN, Gruber M.
Invasion is not an independent prognostic factor in high-grade glioma.
J Cancer Res Ther. 2011 Jul;7(3):331-5.
Abstract |
Reprint |
Related articles
|
|
|
Nieder C.
A
Thought-Provoking Retrospective Study on Survival and Toxicity After
Reirradiation for Recurrent High-Grade Gliomas.
J
Clin Oncol. 2010 Dec 28. [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
|
Park
CK, Lee SH, Han JH, Kim CY, Kim DW, Paek SH, Kim DG, Heo DS, Kim IH, Jung HW.
Recursive partitioning analysis of prognostic factors in WHO grade III
glioma patients treated with radiotherapy or radiotherapy plus chemotherapy
BMC Cancer. 2009 Dec 18;9(1):450. [Epub ahead of print]
Abstract |
Reprint
|
|
|
Rineer
J, Schreiber D, Choi K, Rotman M.
Characterization and outcomes of infratentorial malignant glioma: A
population-based study using the Surveillance Epidemiology and End-Results
database
Radiother Oncol. 2010 May 5;. [Epub ahead of print]
Abstract
|
|
|
Ritz
R, Müller M, Dietz K, Duffner F, Bornemann A, Roser F, Tatagiba M
Hypericin uptake: A prognostic marker for survival in high-grade glioma
J Clin Neurosci. 2008 Apr 3;. [Epub ahead of print]
Abstract
|
|
|
Sands SA, Zhou T, O'Neil SH, Patel SK, Allen J, McGuire Cullen P, Kaleita
TA, Noll R, Sklar C, Finlay JL.
Long-Term
Follow-Up of Children Treated for High-Grade Gliomas: Children's Oncology
Group L991 Final Study Report.
J
Clin Oncol. 2012 Feb 21. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Tendulkar RD, Pai Panandiker AS, Wu S, Kun LE, Broniscer A,
Sanford RA, Merchant TE.
Irradiation of Pediatric High-Grade Spinal Cord Tumors
Int J Radiat Oncol Biol Phys. 2010 Mar 24;. [Epub ahead of print]
Abstract
|
|
|
Zhu YJ, Zhu XD, Wang SH, Shen F, Shen H, Liu WG.
A multivariate analysis of the prognostic factors of grade III gliomas
Chin Med J (Engl). 2008 Jun 20;121(12):1072-5
Abstract |
Full Text |
Reprint
|
|
Histological Subtype
|
|
|
|
Shirai
K, Suzuki Y, Okamoto M, Wakatsuki M, Noda SE, Takahashi T, Ishiuchi S,
Hasegawa M, Nakazato Y, Nakano T.
Influence of Histological Subtype on Survival after Combined Therapy of
Surgery and Radiation in WHO Grade 3 Glioma.
J Radiat Res (Tokyo). 2010 Sep 29;51(5):589-94.
Abstract |
Reprint |
Related articles
|
|
Radiation
Necrosis
|
|
|
|
Rusthoven
KE, Olsen C, Franklin W, Kleinschmidt-Demasters BK, Kavanagh BD, Gaspar LE,
Lillehei K, Waziri A, Damek DM, Chen C
Favorable Prognosis in Patients with High-Grade Glioma with Radiation
Necrosis: The University of Colorado Reoperation Series
Int J Radiat Oncol Biol Phys. 2010 Aug 21;. [Epub ahead of print]
Abstract
|
|
|
Genetic
Alterations
|

|
|
|
|
Kreth
S, Thon N, Eigenbrod S, Lutz J, Ledderose C, Egensperger R, Tonn JC,
Kretzschmar HA, Hinske LC, Kreth FW.
O-Methylguanine-DNA Methyltransferase (MGMT) mRNA Expression Predicts
Outcome in Malignant Glioma Independent of MGMT Promoter Methylation.
PLoS One. 2011 Feb 18;6(2):e17156.
Abstract |
Reprint |
Related articles
|
|
|
Olson
RA, Brastianos PK, Palma DA.
Prognostic
and predictive value of epigenetic silencing of MGMT in patients with high
grade gliomas: a systematic review and meta-analysis.
J
Neurooncol. 2011 Apr 27. [Epub
ahead of print]
Abstract |
Related articles
|
|
|
|
|